Mitochondria-specific pro-apoptotic activity of genistein lipidic nanocarriers

Molecular Pharmaceutics

Volumn 10, Issue 10, 2013, Pages 3789-3800

  Pham, Jimmy ^a   Brownlow, Bill ^b   Elbayoumi, Tamer ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

Author keywords

Caspase enzymes; Cytochrom c; Micelles; Mitochondriotropic; Nanoemulsions; Proapoptotic

Indexed keywords

CASPASE 9; CYTOCHROME C; DOXORUBICIN; GENISTEIN; LIPID; MACROGOL; NANOCARRIER; POLYUNSATURATED FATTY ACID;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOSOL; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG STABILITY; HUMAN; HUMAN CELL; LIPOPHILICITY; MEMBRANE DEPOLARIZATION; MICELLE; MITOCHONDRIAL MEMBRANE; MOUSE; NANOEMULSION; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CASPASES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROMES C; EMULSIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENISTEIN; HEP G2 CELLS; HUMANS; ISOFLAVONES; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICELLES; MITOCHONDRIA;

EID: 84888316891     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp4004892     Document Type: Article

References (32)

1. Wang, H. K. The therapeutic potential of flavonoids. Expert Opin. Invest. Drugs 2000, 9 (9), 2103-19.
2. Valachovicova, T.; Slivova, V.; Sliva, D. Cellular and physiological effects of soy flavonoids. Mini-Rev. Med. Chem. 2004, 4 (8), 881-7.
3. Alhasan, S. A.; Pietrasczkiwicz, H.; Alonso, M. D.; Ensley, J.; Sarkar, F. H. Genistein-induced cell cycle arrest and apoptosis in a head and neck squamous cell carcinoma cell line. Nutr. Cancer 1999, 34 (1), 12-9.
4. Banerjee, S.; Li, Y.; Wang, Z.; Sarkar, F. H. Multi-targeted therapy of cancer by genistein. Cancer Lett. 2008, 269 (2), 226-42.
5. Li, Y.; Upadhyay, S.; Bhuiyan, M.; Sarkar, F. H. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 1999, 18 (20), 3166-72.
6. Baxa, D. M.; Yoshimura, F. K. Genistein reduces NF-kappa B in T lymphoma cells via a caspase-mediated cleavage of I kappa B alpha. Biochem. Pharmacol. 2003, 66 (6), 1009-18.
7. Lamartiniere, C. A.; Moore, J. B.; Brown, N. M.; Thompson, R.; Hardin, M. J.; Barnes, S. Genistein suppresses mammary cancer in rats. Carcinogenesis 1995, 16 (11), 2833-40.
8. Yoshimura, F. K. Genistein induces apoptosis via mitochondrial damage in acute lymphoblastic leukemia T-cell lines. Cancer Ther. 2004, 2 (1), 429-440.
9. George, J.; Banik, N. L.; Ray, S. K. Genistein induces receptor and mitochondrial pathways and increases apoptosis during BCL-2 knockdown in human malignant neuroblastoma SK-N-DZ cells. J. Neurosci. Res. 2010, 88 (4), 877-86.
10. Costantini, P.; Jacotot, E.; Decaudin, D.; Kroemer, G. Mitochondrion as a novel target of anticancer chemotherapy. J. Natl. Cancer Inst. 2000, 92 (13), 1042-53.
11. Baxa, D. M.; Luo, X.; Yoshimura, F. K. Genistein induces apoptosis in T lymphoma cells via mitochondrial damage. Nutr. Cancer 2005, 51 (1), 93-101.
12. Merchant, K.; Kumi-Diaka, J.; Rathinavelu, A.; Esiobu, N.; Zoeller, R.; Hartmann, J.; Johnson, M. Molecular basis of the anticancer effects of genistein isoflavone in LNCaP prostate cancer cells. Funct. Foods Health Dis. 2011, 1 (3), 91-105.
13. Weissig, V. Targeted drug delivery to mammalian mitochondria in living cells. Expert Opin. Drug Delivery 2005, 2 (1), 89-102.
14. Horobin, R. W.; Trapp, S.; Weissig, V. Mitochondriotropics: a review of their mode of action, and their applications for drug and DNA delivery to mammalian mitochondria. J. Controlled Release 2007, 121 (3), 125-36.
15. Trapp, S.; Horobin, R. W. A predictive model for the selective accumulation of chemicals in tumor cells. Eur. Biophys. J. 2005, 34 (7), 959-66.
16. Trapp, S.; Rosania, G. R.; Horobin, R. W.; Kornhuber, J. Quantitative modeling of selective lysosomal targeting for drug design. Eur. Biophys. J. 2008, 37 (8), 1317-28.
17. Rashid, F.; Horobin, R. W. Accumulation of fluorescent noncationic probes in mitochondria of cultured cells: observations, a proposed mechanism, and some implications. J. Microsc. 1991, 163 (Part 2), 233-41.
18. Whaley, W. L.; Rummel, J. D.; Kastrapeli, N. Interactions of genistein and related isoflavones with lipid micelles. Langmuir 2006, 22 (17), 7175-84.
19. Weissig, V. Mitochondrial delivery of biologically active molecules. Pharm. Res. 2011, 28 (11), 2633-8.
20. Mu, L.; Elbayoumi, T. A.; Torchilin, V. P. Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and dalpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin. Int. J. Pharm. 2005, 306 (1-2), 142-9.
21. Jordan, M.; Nayel, A.; Brownlow, B.; Elbayoumi, T. Development and Evaluation of Tocopherol-Rich Argan Oil-Based Nanoemulsions as Vehicles Possessing Anticancer Activity. J. Biomed. Nanotechnol. 2012, 8 (6), 944-56.
22. Elbayoumi, T. A.; Torchilin, V. P. Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines. Eur. J. Pharm. Sci. 2007, 32 (3), 159-68.
23. Tang, J.; Xu, N.; Ji, H.; Liu, H.; Wang, Z.; Wu, L. Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment. Int. J. Nanomed. 2011, 6, 2429-35.
24. Cannava, C.; Crupi, V.; Ficarra, P.; Guardo, M.; Majolino, D.; Mazzaglia, A.; Stancanelli, R.; Venuti, V. Physico-chemical characterization of an amphiphilic cyclodextrin/genistein complex. J. Pharm. Biomed. Anal. 2010, 51 (5), 1064-8.
25. Kwon, S. H.; Kim, S. Y.; Ha, K. W.; Kang, M. J.; Huh, J. S.; Im, T. J.; Kim, Y. M.; Park, Y. M.; Kang, K. H.; Lee, S.; Chang, J. Y.; Lee, J.; Choi, Y. W. Pharmaceutical evaluation of genistein-loaded pluronic micelles for oral delivery. Arch. Pharm. Res. 2007, 30 (9), 1138-43.
26. Bronikowska, J.; Szliszka, E.; Czuba, Z. P.; Zwolinski, D.; Szmydki, D.; Krol, W. The combination of TRAIL and isoflavones enhances apoptosis in cancer cells. Molecules 2010, 15 (3), 2000-15.
27. Biswas, S.; Dodwadkar, N. S.; Sawant, R. R.; Koshkaryev, A.; Torchilin, V. P. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting. J. Drug Targeting 2011, 19 (7), 552-61.
28. Boddapati, S. V.; D'Souza, G. G.; Erdogan, S.; Torchilin, V. P.; Weissig, V. Organelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Lett. 2008, 8 (8), 2559-63.
29. Patel, N. R.; Hatziantoniou, S.; Georgopoulos, A.; Demetzos, C.; Torchilin, V. P.; Weissig, V.; D'Souza, G. G. Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol. J. Liposome Res. 2010, 20 (3), 244-9.
30. Pawlikowska-Pawlega, B.; Misiak, L. E.; Zarzyka, B.; Paduch, R.; Gawron, A.; Gruszecki, W. I. Localization and interaction of genistein with model membranes formed with dipalmitoylphosphatidylcholine (DPPC). Biochim. Biophys. Acta 2012, 1818 (7), 1785-93.
31. Yoon, H. S.; Moon, S. C.; Kim, N. D.; Park, B. S.; Jeong, M. H.; Yoo, Y. H. Genistein induces apoptosis of RPE-J cells by opening mitochondrial PTP. Biochem. Biophys. Res. Commun. 2000, 276 (1), 151-6.
32. Lee, S. H.; Kim, Y. H.; Yu, H. J.; Cho, N. S.; Kim, T. H.; Kim, D. C.; Chung, C. B.; Hwang, Y. I.; Kim, K. H. Enhanced bioavailability of soy isoflavones by complexation with beta-cyclodextrin in rats. Biosci., Biotechnol., Biochem. 2007, 71 (12), 2927-33.